AONN+ Statement of Professional Responsibility to Ensure Racial and Health Equity

News & Updates published on June 4, 2020 in News & Updates

The Academy of Oncology Nurse & Patient Navigators (AONN+) is dedicated to improving patient care and quality of life. We are committed to supporting the professional workforce that has historically served cancer patients in greatest need. This includes patients of color who have long dealt with systemic and institutional injustices and racial inequities. These impacts have been well documented in our health and cancer care systems and were the catalyst to create the profession of navigation.

We stand at a moment of national tragedy, built on a history of racial injustice. This is compounded by the disproportionate impact of COVID-19 on communities of color. Navigators work to make our healthcare system a more just and equitable place as they help patients identify personal strengths to empower their preference and priorities. They bear witness to the extraordinary challenges facing all cancer patients. A core competency of patient navigation is to demonstrate sensitivity and responsiveness to a diverse patient population, including, but not limited to, diversity in race, ethnicity, gender, age, culture, religion, abilities, and sexual orientation. With this basic value, all navigators work to expose health inequities and find solutions to ensure that all people have the opportunity to live healthy, fulfilling lives as they respond to patient needs and barriers. The need for this work has never been more profound. AONN+ implores all navigators to recommit in this moment to their professional obligations to advance racial and health equity.

Related Items
Colorectal Cancer Screening Update: with Andi Dwyer, MPH
News & Updates published on June 23, 2026 in News & Updates
In this interview, AONN+ Board of Trustees member Andi Dwyer discusses the American Cancer Society’s updated colorectal cancer screening guidelines, including new stool-based tests and the first-ever recommendation of an FDA-approved blood-based screening test, while emphasizing that colonoscopy and stool tests remain the most effective tools for early detection and prevention.
AONN+ Joins Pfizer’s 7th Annual Advocacy Luncheon at ASCO 2026
News & Updates published on June 23, 2026 in News & Updates
Pfizer’s 7th Annual Advocacy Luncheon at ASCO 2026 brought together advocacy leaders, including AONN+ Executive Director Candice Roth, MSN, RN, CENP, to discuss emerging cancer therapies, the role of artificial intelligence in patient-centered care, and the launch of Pfizer’s new Patient Advocacy360 partnership framework.
AONN+ Takes Part in CAR T Vision Coalition Event
News & Updates published on June 23, 2026 in News & Updates
Candice Roth, MSN, RN, CENP, and Monica Dean represented AONN+ at the launch of the first U.S. CAR T Vision to Action Blueprint, a stakeholder-driven initiative that provides practical strategies and tools to address access barriers and expand the use of CAR T-cell therapy for eligible patients nationwide by 2030.